Merck

MRK · NYSE · USD

$144.30+0.34%+$0.49

Close · October 2, 2026

At a glance

Revenue growth
+1.31%
2025 vs 2024
Net income growth
+6.64%
2025 vs 2024
Net margin
28.1%
2024: 26.7%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets129,802128,685136,866129,546117,523115,122117,106117,532112,630105,849106,675106,727
Current assets36,67935,01543,51647,55737,06535,50338,78240,36138,20531,44532,16831,954
Cash and equivalents6,8495,32714,56518,1698,0078,62913,24214,59311,3045,5796,8418,605
Short-term investments292375—45.0615599447—50.040.0252168
Receivables13,42813,05112,70612,99912,71611,58411,12712,54412,97112,57211,07211,674
Inventory6,2076,4796,6586,4446,6016,1966,1096,2446,4696,5106,3586,131
Net property, plant and equipment25,73725,43326,82325,63925,23624,79325,14923,44623,22123,04524,48822,526
Goodwill21,58221,58121,57921,58721,59121,68421,66821,69721,16121,18121,19721,183
Other intangible assets24,97825,74526,68115,31315,19315,75816,37017,01016,98417,57218,01119,199
Long-term investments2,3522,2812,0822,2571,9411,7931,6101,8501,6011,5541,5582,636
Current liabilities27,73126,94528,32728,62826,03725,17428,42029,58626,06025,09925,69423,094
Accounts payable3,9193,9624,5154,3064,0233,9624,9995,4685,2155,5074,4344,218
Long-term debt51,08646,67346,75039,96933,96833,48434,46234,98234,71731,14233,68333,980
Total debt51,08646,67350,24539,96933,96833,48438,12134,98234,71731,142——
Total liabilities87,81882,75484,20477,63968,46366,72270,73472,97268,98265,42569,04065,427
Total equity (incl. minority)41,98445,93152,66251,90749,06048,40046,37244,56043,64840,42437,63541,300
Retained earnings63,26966,72173,07572,23168,47766,09763,06961,38460,18756,69753,89557,082
Minority interest51.053.056.057.067.065.059.058.066.060.054.054.0